Oganesyan Vaheh, Damschroder Melissa M, Phipps Sandrina, Wilson Susan D, Cook Kimberly E, Wu Herren, Dall'Acqua William F
Department of Antibody Discovery and Protein Engineering, MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Jun 1;66(Pt 6):730-3. doi: 10.1107/S1744309110015861. Epub 2010 May 29.
The recombinant N-terminal domain of human ephrin type-A receptor 2 (rEphA2) has been crystallized in complex with the recombinantly produced Fab fragment of a fully human antibody (1C1; IgG1/kappa). These are the first reported crystals of an ephrin receptor bound to an antibody. The orthorhombic crystals belonged to space group C222(1) (the 00l reflections obey the l = 2n rule), with unit-cell parameters a = 78.93, b = 120.79, c = 286.20 A. The diffraction of the crystals extended to 2.0 A resolution. However, only data to 2.55 A resolution were considered to be useful owing to spot overlap caused by the long unit-cell parameter. The asymmetric unit is most likely to contain two 1C1 Fab-rEphA2 complexes. This corresponds to a crystal volume per protein weight (V(M)) of 2.4 A(3) Da(-1) and a solvent content of 49.5%. The three-dimensional structure of this complex will shed light on the molecular basis of 1C1 specificity. This will also contribute to a better understanding of the mechanism of action of this antibody, the current evaluation of which as an antibody-drug conjugate in cancer therapy makes it a particularly interesting case study.
人 EphA2 型受体的重组 N 端结构域(rEphA2)已与一种全人源抗体(1C1;IgG1/kappa)的重组 Fab 片段形成复合物并结晶。这些是首次报道的 Ephrin 受体与抗体结合的晶体。正交晶体属于空间群 C222(1)(00l 反射服从 l = 2n 规则),晶胞参数 a = 78.93、b = 120.79、c = 286.20 Å。晶体的衍射延伸至 2.0 Å 分辨率。然而,由于长晶胞参数导致的斑点重叠,仅 2.55 Å 分辨率的数据被认为是有用的。不对称单元很可能包含两个 1C1 Fab-rEphA2 复合物。这对应于每蛋白质重量的晶体体积(V(M))为 2.4 ų Da⁻¹,溶剂含量为 49.5%。该复合物的三维结构将阐明 1C1 特异性的分子基础。这也将有助于更好地理解该抗体的作用机制,目前将其作为癌症治疗中的抗体药物偶联物进行评估,使其成为一个特别有趣的案例研究。